GlaxoSmithKline Announces Approval of New Dosage Strength of ZANTAC Tablets for the treatment of gastroesophageal reflux disease (GERD) in children one month and older. Read more.
Comments
No comments yet. Leave a Comment
Explore Heartburn / GERD
